SynthesisArchives of dermatological research2024
Role of IL-23 inhibitors including risankizumab and guselkumab in the treatment of pityriasis rubra pilaris.
Syed Minhaj Rahman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it